Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927158 · ClinicalTrials.gov registry record
Exome and Genome Analysis to Elucidate Genetic Etiologies and Population Characteristics in the Plain Community
A clinical trial of Undiagnosed Disease, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT02927158: Recruiting study of Undiagnosed Disease, sponsored by University of Pittsburgh.
NCT02927158 is a study of Undiagnosed Disease that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02927158, a study of Undiagnosed Disease, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to utilize whole exome and whole genome sequencing techniques to identify underlying genetic causes for undiagnosed disorders in the Plain Communities, and to do population genetic studies looking at genetic drift and founder mutations in this unique population.
Primary Outcome
Each participant will be sequenced and DNA data will be analyzed for gene mutations consistent with the clinical symptomatology
Conditions Studied
Study Locations (1)
Pennsylvania
- Children's Hospital of Pittsburgh of UPMC - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-08 |
| Est. Completion | 2040-08 |
What NCT02927158 shows while recruiting
NCT02927158 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Undiagnosed Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02927158 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02927158 about?
NCT02927158 is a clinical study titled "Exome and Genome Analysis to Elucidate Genetic Etiologies and Population Characteristics in the Plain Community". This study is designed to utilize whole exome and whole genome sequencing techniques to identify underlying genetic causes for undiagnosed disorders in the Plain Communities, and to do population genetic studies looking at genetic drift and founder mutations in this unique population.
What is the current status of trial NCT02927158?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2016-08. Estimated completion is 2040-08.
What conditions does trial NCT02927158 study?
This clinical trial studies the following conditions: Undiagnosed Disease.
Who is sponsoring clinical trial NCT02927158?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02927158 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Undiagnosed Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia